These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21672886)

  • 1. Thioctic acid-induced acute cholestatic hepatitis.
    Ridruejo E; Castiglioni T; Silva MO
    Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin-induced acute cholestatic hepatitis.
    Aygun C; Kocaman O; Gurbuz Y; Senturk O; Hulagu S
    World J Gastroenterol; 2007 Oct; 13(40):5408-10. PubMed ID: 17879418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cholestatic hepatitis induced by fenofibrate.
    Hajdu D; Aiglová K; Vinklerová I; Urbánek K
    J Clin Pharm Ther; 2009 Oct; 34(5):599-602. PubMed ID: 19744016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable drug-induced liver injury associated with aliskiren: case report and review of adverse event reports from pharmacovigilance databases.
    Crepin S; Godet B; Carrier P; Villeneuve C; Merle L; Laroche ML
    Am J Health Syst Pharm; 2014 Apr; 71(8):643-7. PubMed ID: 24688038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate-induced acute cholestatic hepatitis.
    Ho CY; Kuo TH; Chen TS; Tsay SH; Chang FY; Lee SD
    J Chin Med Assoc; 2004 May; 67(5):245-7. PubMed ID: 15357112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propafenone-induced liver injury.
    Spinler SA; Elder CA; Kindwall KE
    Ann Pharmacother; 1992; 26(7-8):926-8. PubMed ID: 1354511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
    J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib-induced hepatitis complicated by fatal lactic acidosis in an elderly man with lung cancer.
    Pellegrinotti M; Fimognari FL; Franco A; Repetto L; Pastorelli R
    Ann Pharmacother; 2009 Mar; 43(3):542-5. PubMed ID: 19261961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.